These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7903288)

  • 21. Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma.
    Felix A; El-Naggar AK; Press MF; Ordonez NG; Fonseca I; Tucker SL; Luna MA; Batsakis JG
    Hum Pathol; 1996 Jun; 27(6):561-6. PubMed ID: 8666365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical detection of early-stage carcinogenesis of oral leukoplakia by increased DNA-instability and various malignancy markers.
    Iwasa M; Imamura Y; Noriki S; Nishi Y; Kato H; Fukuda M
    Eur J Histochem; 2001; 45(4):333-46. PubMed ID: 11846001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical application of proliferating cell nuclear antigen, oncoprotein p53 and tumor front grading analysis in patients operated on for laryngeal cancer.
    Morawski K; Gabriel A; Namyslowski G; Ziólkowski A; Pietrawska V; Steplewska K
    Eur Arch Otorhinolaryngol; 1999; 256(8):378-83. PubMed ID: 10525938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings.
    Nishioka H; Hiasa Y; Hayashi I; Kitahori Y; Konishi N; Sugimura M
    Oncology; 1993; 50(6):426-9. PubMed ID: 7901826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of EGFR and PCNA, and DNA content in squamous cell carcinoma of larynx].
    Ling L; Zhou MY; Wang HE
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Mar; 14(3):99-101. PubMed ID: 12541404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal evolution and progression of 20-methylcholanthrene-induced squamous cell carcinoma of mouse epidermis as revealed by DNA instability and other malignancy markers.
    Hirai K; Kumakiri M; Ueda K; Imamura Y; Noriki S; Nishi Y; Kato H; Fukuda M
    Eur J Histochem; 2001; 45(4):319-32. PubMed ID: 11846000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers.
    Welkoborsky HJ; Hinni M; Dienes HP; Mann WJ
    Ann Otol Rhinol Laryngol; 1995 Jul; 104(7):503-10. PubMed ID: 7598360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
    Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
    Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in expression of p53, proliferating cell nuclear antigen and bcl-2 in recurrent laryngeal cancer after radiotherapy.
    Lee BJ; Wang SG; Roh HJ; Goh EK; Chon KM; Park DY
    J Laryngol Otol; 2006 Jul; 120(7):579-82. PubMed ID: 16672091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between proliferating cell nuclear antigen (PCNA), nuclear DNA content and mutant p53 during genesis of cervical carcinoma.
    Steinbeck RG; Heselmeyer KM; Moberger HB; Auer GU
    Acta Oncol; 1995; 34(2):171-6. PubMed ID: 7718254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
    Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
    Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination.
    Franchi A; Gallo O; Boddi V; Santucci M
    Clin Cancer Res; 1996 Oct; 2(10):1801-8. PubMed ID: 9816133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma.
    Hirvikoski P; Kumpulainen E; Virtaniemi J; Johansson R; Haapasalo H; Marin S; Halonen P; Helin H; Raitiola H; Pukander J; Kellokumpu-Lehtinen P; Kosma VM
    J Clin Oncol; 1997 Sep; 15(9):3111-20. PubMed ID: 9294474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder].
    Offner FA; Schäfer G; Hittmair A; Ofner D; Grünewald K; Weyrer K; Mattern D; Eberle J; Mikuz G; Feichtinger H
    Verh Dtsch Ges Pathol; 1993; 77():241-6. PubMed ID: 7511289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
    Lee CS
    Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of p53, p21, PCNA and COX-2 and its relationship with recurrence in the early-stage laryngeal cancer with negative surgical margin].
    Zeng R
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Mar; 30(5):349-52, 356. PubMed ID: 27382672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential biomarkers in predicting progression of epithelial hyperplastic lesions of the larynx.
    Gallo O; Franchi A; Chiarelli I; Porfirio B; Grande A; Simonetti L; Bocciolini C; Fini-Storchi O
    Acta Otolaryngol Suppl; 1997; 527():30-8. PubMed ID: 9197477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China.
    Chen H; Wang LD; Guo M; Gao SG; Guo HQ; Fan ZM; Li JL
    World J Gastroenterol; 2003 Jan; 9(1):16-21. PubMed ID: 12508343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.